"We are using machine learning tools with routinely collected data to identify people with heart failure earlier, so that they can get the right treatment and prevent hospital admissions and death ...

People with chronic kidney disease or those at risk of heart failure are greatly affected by potassium imbalances in the body. These can even be life-threatening. While wearable glucose monitors ...

He lives it every day, as he and his fellow researchers study and reprogram the potential of the blood to treat disease, specifically heart failure in children. Building on the work of Dr.

Sci & Tech and currently in Phase III for Systolic Heart Failure. According to GlobalData, Phase III drugs for Systolic Heart Failure have a 63% phase transition success rate (PTSR) indication ...

SRD-002 is under clinical development by Sardocor and currently in Phase II for Diastolic Heart Failure (HFpEF).